Tavapadon is an investigational, novel, once-daily treatment option for Parkinson’s disease, which currently affects more ...

Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, today announced positive results from its Phase 1 trial evaluating ...

Switching off a single enzyme in immune cells protected mice from obesity, type 2 diabetes, and fatty liver disease in a new ...

Structural and computational approaches uncover the molecular basis for dimerization, open-closed conformational transitions, and the dynamic behavior of the human angiotensin-I converting enzyme ...

This work presents valuable new data on the role of D-Serine and how it competes with its stereoisomer L-Serine to influence metabolism. The work presents a variety of solid experimental data combined ...

Kayothera, Inc. ("Kayothera"), a preclinical therapeutics company developing first-in-class, small molecule inhibitors of the ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

This article was reviewed by Kelly Brown MD, MBA. You’ve been prescribed Viagra, or the generic version sildenafil, and ...

The outlook for the KAT6 inhibitors market is strengthening as interest in epigenetic targets grows and KAT6A/B gain ...

Profs Ravi Acharya and Edward Sturrock review the historical foundation, present landscape and future clinical promise of ACE inhibition.

In the cancer type multiple myeloma, the malignant cells differ significantly from normal cells regarding the layer of ...